Ian Pollack, MD, is Chief of Pediatric Neurosurgery at UPMC Children’s Hospital of Pittsburgh, A. Leland Albright Professor of Neurosurgery, and vice-chair for Academic Affairs at the University of Pittsburgh School of Medicine. He is professor of clinical and translational science and distinguished professor of neurosurgery at the University of Pittsburgh. Dr. Pollack is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, Posterior Fossa Decompression, and Craniectomy.

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Felker is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Brain Stem Cancer, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC. Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.

Costas G. Hadjipanayis, MD, PhD, is a board-certified neurosurgeon who has devoted his entire career to the treatment of brain tumor patients. He completed his neurosurgical residency and graduate PhD training at the University of Pittsburgh with additional neurosurgical oncology training at the University of California, San Francisco. Dr. Hadjipanayis is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response. Dr. Flickinger is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Vertebroplasty, and Gamma Knife Radiosurgery.

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. Dr. Maurer is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Infantile Neutropenia, Rosai-Dorfman Disease, Leukemia, and Pediatric Low-Grade Glioma (pLGG).

Frank Lieberman is a Neurologist in Pittsburgh, Pennsylvania. Dr. Lieberman is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

Megan M. Mantica, MD, is an assistant professor of neurology and medicine at the University of Pittsburgh School of Medicine in the division of hematology/oncology. She specializes in the treatment of adult high grade gliomas, central nervous system lymphoma, and neurological complications of cancer treatment. Her translational research interests include womenís neuro-oncology, reproductive neuro-oncology and metastatic brain disease, and high grade gliomas. Dr. Mantica is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, and Astrocytoma.

Michael Farrell is a primary care provider, practicing in Internal Medicine in Pittsburgh, Pennsylvania. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Chronic Pain, Creutzfeldt-Jakob Disease, Diffuse Midline Glioma H3 K27M-Mutant, Osteotomy, and Thrombectomy.

Hideho Okada is a Neurosurgery provider in Pittsburgh, Pennsylvania. Dr. Okada is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, Glioblastoma, and Endoscopy.

Benison Lau, MD, specializes in pediatric hematology oncology and is board-certified in pediatrics by the American Board of Pediatrics and internal medicine and American Board of Internal Medicine. He is affiliated with UPMC Children's Hospital of Pittsburgh. Dr. Lau completed his residency at the University of Massachusetts Medical School and medical degree at the University of Illinois College of Medicine at Peoria. Dr. Lau is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioma, Thalassemia, Diffuse Midline Glioma H3 K27M-Mutant, Immune Thrombocytopenic Purpura (ITP), and Deep Brain Stimulation.